← All drugs Report issue

dsp-2230

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Sodium channel protein type X alpha subunitBLOCKER
SCN10A blocker
- Sodium channel protein type 10 subunit alpha (SCN10A) ↗
Sodium channel protein type IX alpha subunitBLOCKER
SCN9A blocker
- Sodium channel protein type 9 subunit alpha (SCN9A) ↗

Chemistry & pharmacology

Loading structure…

SMILES

C[C@@H](NCc1nc2ccc(Oc3cc(F)c(F)c(F)c3)nc2n1C1CCC1)C(N)=O

Mol. weight: 419.41 g/mol
Lipinski Ro5: Pass
Rule of 3: No
Chirality: Single Stereoisomer
Inorganic: No
Polymer: No

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL5095026 ↗
ChEMBLCHEMBL3545012 ↗

Also known as

dsp-2230